Johnson & Johnson Vision Care, Inc. recalls ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
- Recall date
- June 12, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2163-2025
- FDA classification
- Class II
- Brand / firm
- Johnson & Johnson Vision Care, Inc.
- Sold / distributed
- Worldwide - U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, DE, FL, GA, HI, IA, IL, IN, KN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NV, NY, OH, PA, SC TN, TX, UT, VA, WA, WI, and WY. The countries of Belgium, Bermuda, Canada, Switzerland, Denmark, Germany, Spain, France, United…
Why it was recalled
Due to defects (bubbles/voids) identified during standard finished goods testing
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
Get recall alerts
Free email alert whenever Johnson & Johnson Vision Care, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Johnson & Johnson Vision Care, Inc.